timothy sykes logo
VTAK Stock Draws Traders As Flyte Bets On AI Aviation Thumbnail
G Google News

VTAK Stock Draws Traders As Flyte Bets On AI Aviation

JACK KELLOGG•UPDATED JUN. 23, 2026, 9:19 AM ET
Reviewed by Ellis Hobbsand Fact-checked by Matt Monaco

Catheter Precision Inc. stocks have been trading up by 33.38 percent amid heightened optimism from its most recent positive developments.

Key Takeaways

  • Catheter Precision, parent of Flyte, led a $2.2M strategic PIPE into Volato Group to fund AI-driven private aviation and regional air mobility.
  • Through Flyte, VTAK bought about 2.9M Volato shares, taking a roughly 7.5% stake and becoming its largest shareholder.
  • Catheter Precision’s shares gained nearly 3% after the Volato deal and collaboration plans were announced.
  • Flyte also partnered with GSE Worldwide and PGA TOUR golfer Emiliano Grillo, showcasing its Cirrus Vision Jet short-haul service at the 2026 U.S. Open.

Candlestick Chart

Live Update At 09:18:55 EDT: On Tuesday, June 23, 2026 Catheter Precision Inc. stock [NYSE American: VTAK] is trending up by 33.38%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

VTAK is trading like a classic speculative small-cap: choppy, headline-sensitive, and unforgiving when the story wobbles. Over the recent stretch, Catheter Precision shares slid from the $1.05–$1.10 area toward roughly $0.87, showing steady selling pressure despite brief pops. The intraday tape shows VTAK spiking as high as about $1.55 before fading hard, a pattern momentum traders know well — early squeezes followed by profit-taking and sharp reversals.

On the fundamentals, Catheter Precision is still very much in “build mode.” Quarterly revenue sits around $432,000, with trailing revenue near $819,000, but losses are heavy. The latest quarter shows a net loss from continuing operations of about $1.69M and free cash flow near -$2.8M. Profitability ratios are deeply negative, even as gross margin stands at a strong 91.5%, which tells traders the core product economics are attractive, but overhead and growth spending are crushing the bottom line.

More Breaking News

The balance sheet shows only $441,000 in cash against current liabilities of about $19.7M and working capital of roughly -$18.5M. VTAK also relies on financing cash flows, with $4.47M coming in last quarter. For traders, that all screams dilution risk, but also explains why management is chasing higher-upside stories like Flyte and AI-enabled aviation.

Why Traders Are Watching VTAK’s Flyte And Volato Deals

The real story pulling traders toward VTAK right now lives inside its Flyte subsidiary. Catheter Precision stepped outside its traditional medical niche and led a $2.2M strategic PIPE into Volato Group, a private aviation player focused on AI-enabled operations and regional air mobility. That is not a small side bet. Through Flyte, Catheter Precision picked up about 2.9M Volato (SOAR) shares, building a roughly 7.5% stake and becoming Volato’s largest shareholder.

For traders, that instantly shifts VTAK’s narrative from a pure-play medical device turnaround to a hybrid story tied to private jets, AI routing, and regional air mobility. The market took notice. Catheter Precision’s stock jumped nearly 3% on the Volato news, a clear sign traders were willing to reward management for taking a swing at a bigger, faster-growing ecosystem.

This is not a passive financial position. By controlling 7.5% of Volato, Catheter Precision — via Flyte — gains influence and a front-row seat to how AI can reshape scheduling, fleet utilization, and customer experience in private aviation. VTAK is effectively trying to bolt its Flyte regional air mobility platform onto Volato’s network, turning the stake into a strategic bridge.

At the same time, Flyte is working the demand side. The partnership with sports talent agency GSE Worldwide and PGA TOUR golfer Emiliano Grillo, showcased at the 2026 U.S. Open, is a targeted push at high-spend travelers. Flyte is marketing Cirrus Vision Jet-based short-haul service to pro athletes and the broader sports ecosystem. That gives VTAK a clear, premium audience to test pricing, routing, and service quality while building brand credibility fast.

For active traders, VTAK now trades like a story stock tied to execution in AI aviation, not just quarterly medical device numbers.

Conclusion

Catheter Precision and its VTAK ticker are in a high-risk, high-upside zone where story and execution matter more than last quarter’s EPS. The Flyte strategy — a 7.5% Volato stake, becoming its largest shareholder, plus the $2.2M PIPE and sports marketing push — tells traders management is betting on an AI-enabled regional air mobility ecosystem. If Flyte can align its platform with Volato’s operations and turn those sports and VIP relationships into repeat flights, the growth narrative around VTAK strengthens.

But the numbers still demand discipline. VTAK’s negative free cash flow, thin cash balance, and heavy losses mean the company is likely to lean on capital markets again. Every rally will attract traders who remember that reality. That is why price action around catalysts — new Flyte contracts, Volato updates, or fresh financing — will be critical.

This is where the Tim Sykes playbook applies. As he often says, “The market rewards preparation, not hope — study the pattern, plan the trade, and always be ready to cut losses fast.” As millionaire penny stock trader and teacher Tim Sykes says, “It’s not about how much money you make; it’s about how much money you keep.”. For traders studying VTAK, that means respecting both sides of the story: the speculative upside of Flyte’s AI aviation push, and the very real financial strain under the hood. Use the volatility for education and research, not blind risk.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

Click Here for a Millionaire's POV on Trading TICKER

Millionaire's
POV on TICKER

Don't miss the next
big breakout.

GET POV
Tim Sykes

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”